VIVO Earnings & Financial Statements - Meridian Bioscience, Inc. logo

VIVO Earnings & Financial Statements

Meridian Bioscience, Inc.

$1.82
-$0.05(-2.67%)
22
Overall
--
Value
10
Tech
34
Quality
How is this score calculated?
Market Cap
$57.45M
Volume
452.89K
52W Range
$1.20 - $6.86
Target Price
$10.00

VIVO earnings and financial statements: Meridian Bioscience, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.

VIVO Annual Financial Statements

VIVO income statement
Fiscal year20262025202420232022
Revenue$2.54M$61.0K$16.0K$4.05M$20.57M
Cost of revenue$1.93M$50.0K$27.0K$8.14M-$20.31M
Operating income-$26.61M-$11.61M-$8.66M-$11.74M-$23.29M
EBITDA-$40.16M-$8.80M-$36.68M-$11.09M-$20.97M
Net income-$49.73M-$17.04M-$43.55M-$24.36M-$42.09M
EPS (diluted)$-2.59$-2.60$-15.17$-9.87$-1.04
VIVO balance sheet
Fiscal year20262025202420232022
Total assets$156.43M$92.74M$37.43M$61.42M$69.66M
Total liabilities$119.49M$75.50M$77.97M$57.67M$47.69M
Shareholders’ equity$36.93M$17.24M-$40.54M$3.75M$21.97M
Cash and equivalents$2.02M$60.0K$199.0K$553.0K$1.28M
Long-term debt$25.41M$16.94M$20.91M$30.00M$23.45M
VIVO cash flow statement
Fiscal year20262025202420232022
Operating cash flow-$3.59M-$7.71M$1.49M-$5.44M-$5.13M
Capital expenditure-----$1.11M
Free cash flow-$4.41M-$7.84M$884.0K-$6.36M-$6.24M
ABCD
1SymbolPriceChangeVol
2VIVO$1.82-2.7%452.89K
3
4
5
6

Get Meridian Bioscience, Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.